ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN REAL PRACTICE: INEQUALITY OF EQUALS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Drugs based on angiotensin-converting enzyme (ACE) inhibitors have individual pharmacokinetic properties that may determine differences in the tissue concentration of ACE inhibitors and their different clinical effects.

Full Text

Restricted Access

About the authors

T. Chernyavskaya

Email: corona1974@mail.ru

References

  1. The Six Report of the Jiont National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure // Arch. Intern. Med. - 1997; 157: 2413-46.
  2. WHO - OSH Hypertension Guidelines Committee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension // J. Hypertens. - 1999; 17: 151-83.
  3. Agabiti-Rosei E., Ambrosioni E., Fimardi G. et al. Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial // Amer. J. Med. - 1992; 92: 79-83.
  4. Neal B., MacMahon S., Chapman N. Blood Pressure Lowering Treament Trialists'Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure lowering drugs: Results of prospectively designed overviews of randomised trials // Lancet. - 2000; 356: 1955-64.
  5. Heran B.S., Wong M.M., Heran I.K. et al. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension // The Cochrane Collaboration. Cochrane database of Systematic Reviews. - 2008; 4. Art. No.:CD003823.D0I:10.1002/14651858.CD003823.pub2
  6. Gerbrandt K.R., Yedinak K.C. Formulary management of ACE inhibitors // Pharmacoeconomics. - 1996; 10 (6): 594-613.
  7. Turnbull F. Blood Pressure Lowering Treatment Trialists'Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials // Lancet. - 2003; 362: 1527-35.
  8. Schwartzkopff B., Brehm M., Mundhenke M. et al. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease // Hypertension. - 2000; 36: 220-5.
  9. Thybo N.K., Stephens N., Cooper A. et al. Effect of antihypertensive treatment on small arteries of patients with previously untriated essential hypertension // Hypertension. - 1995; 25: 474-81.
  10. Филатова Н.П. Применение периндоприла (престариума) при артериальной гипертонии // Тер. арх. - 1995; 67 (9): 81-3.
  11. Asmar R., Topouchian J., Crisan O. et al. Reversion of arterial abnormalities by long-term antihypertensive therapy in large population. The Compilor study // Eur. Heart J. - 2000; 21 (Suppl.): 2366.
  12. Zannad F., Bernaud C.M., Fay R. Double-blind, randomized multicentre comparison of the effects of amlodipine and perindopril on 24-h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators’ Group // Hypertension. - 1999; 17: 137-46.
  13. Терещенко С.Н., Дроздов В.Н., Демидова И.В. и др. Ингибитор ангиотензинпревращающего фермента периндоприл при лечении застойной сердечной недостаточности // Тер. арх. - 1997; 69 (7): 53-6.
  14. Lees K.R., Reid J.L., Scott M.G. et al. Captopril versus perindopril: a double blind study in essential hypertension // Hypertension. - 1989; 3: 17-22.
  15. Grandi A.M., Venco A., Barzizza F. et al. Double-blind comparison of perindopril and captopril in hypertension: effects on left ventricular morphology and function // Hypertension. - 1991; 4: 516-20.
  16. Lees K.R., Reid J.L., Scott M.G. et al. Captopril versus perindopril: a double blind study in essential hypertension // Hypertension. - 1989; 3: 17-22.
  17. Yoshinara K., Sarut T., Abe K. et al. Clinical evalution of monotherapy with perindopril, an ACE inhibitor in the treatment of essential hypertension: double-blind parallel comparison with enalapril // Rinsho Iyaku. - 1997; 13: 4259-97.
  18. Fox K.M., Henderson J.R., Bertrand M.E. et al. The European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA) // Eur. Heart J. - 1998; 19 (Suppl. J): 52-5.
  19. Cleland J.G., Tendera M., Adamus J. et al. Perindopril for the elderly people with chronic heart failure: the PEP-CHF study // Eur. J. Heart Fail. - 1999; 1: 211-7.
  20. Baptista T. et al. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial // Schizophr. Res. - 2007; 93:99-108.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Russkiy Vrach Publishing House